Complete surgical resection of lung tumor decreases exhalation of mutated KRAS oncogene

Respiratory Medicine

Volumn 106, Issue 9, 2012, Pages 1293-1300

  Kordiak, Jacek ^a   Szemraj, Janusz ^a   Hamara, Katarzyna ^a   Bialasiewicz, Piotr ^a   Nowak, Dariusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Benign pulmonary lesion; Exhaled breath condensate; KRAS oncogene mutation; Lung cancer; Surgical treatment

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BREATH ANALYSIS; CANCER TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITOMETRY; DNA DETERMINATION; ELECTROPHORESIS; EXHALATION; EXHALED BREATH CONDENSATE; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; ONCOGENE K RAS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; WILD TYPE;

ADENOCARCINOMA; BREATH TESTS; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENES, RAS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84864580839     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2012.06.019     Document Type: Article

References (44)

1. H.P. Chan, C. Lewis, and P.S. Thomas Exhaled breath analysis: novel approach for early detection of lung cancer Lung Cancer 63 2009 164 168
2. G. Song, T. Qin, H. Liu, G.B. Xu, Y.Y. Pan, and F.X. Xiong Quantitative breath analysis of volatile organic compounds of lung cancer patients Lung Cancer 67 2010 227 231
3. G. Peng, M. Hakim, Y.Y. Broza, S. Billan, R. Abdah-Bortnyak, and A. Kuten Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors Br J Cancer 103 2010 542 551
4. M. Phillips, R.N. Cataneo, A.R. Cummin, A.J. Gagliardi, K. Gleeson, and J. Greenberg Detection of lung cancer with volatile markers in the breath Chest 123 2003 2115 2123 (Pubitemid 36706741)
5. M. Phillips, N. Altorki, J.H. Austin, R.B. Cameron, R.N. Cataneo, and J. Greenberg Prediction of lung cancer using volatile biomarkers in breath Cancer Biomark 3 2007 95 109 (Pubitemid 47103811)
6. M. Corradi, P. Gergelova, and A. Mutti Use of exhaled breath condensate to investigate occupational lung diseases Curr Opin Allergy Clin Immunol 10 2010 93 98
7. C. Gessner, H. Kuhn, K. Toepfer, S. Hammerschmidt, J. Schauer, and H. Wirtz Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patients Lung Cancer 43 2004 215 222 (Pubitemid 38114751)
8. R. Stolarek, P. Bialasiewicz, M. Krol, and D. Nowak Breath analysis of hydrogen peroxide as a diagnostic tool Clin Chim Acta 411 2010 1849 1861
9. Z.L. Borrill, K. Roy, and D. Singh Exhaled breath condensate biomarkers in COPD Eur Respir J 32 2008 472 486
10. G.E. Carpagnano, M.P. Foschino-Barbaro, A. Spanevello, O. Resta, F. Carpagnano, and G. Mule 3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer Am J Respir Crit Care Med 177 2008 337 341 (Pubitemid 351198378)
11. G.E. Carpagnano, M.P. Foschino-Barbaro, G. Mule, O. Resta, S. Tommasi, and A. Mangia 3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer Am J Respir Crit Care Med 172 2005 738 744 (Pubitemid 41324229)
12. W. Han, T. Wang, A.A. Reilly, S.M. Keller, and S.D. Spivack Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients Respir Res 10 2009 86
13. G.E. Carpagnano, A. Spanevello, F. Carpagnano, G.P. Palladino, R. Prato, and D. Martinelli Prognostic value of exhaled microsatellite alterations at 3p in NSCLC patients Lung Cancer 64 2009 334 340
14. G.E. Carpagnano, G.P. Palladino, C. Gramiccioni, M.P. Foschino Barbaro, and D. Martinelli Exhaled ERCC-1 and ERCC-2 microsatellite alterations in NSCLC patients Lung Cancer 68 2010 305 307
15. M. Porta, M. Crous-Bou, P.A. Wark, P. Vineis, F.X. Real, and N. Malats Cigarette smoking and K-ras mutations in pancreas, lung and colorectal adenocarcinomas: etiopathogenic similarities, differences and paradoxes Mutat Res 682 2009 83 93
16. P. Keohavong, M.A. DeMichele, A.C. Melacrinos, R.J. Landreneau, R.J. Weyant, and J.M. Siegfried Detection of K-ras mutations in lung carcinomas: relationship to prognosis Clin Cancer Res 2 1996 411 418 (Pubitemid 26074623)
17. L.F. Zhang, W.M. Gao, R. Gealy, J. Weissfeld, E. Elder, and T.L. Whiteside Comparison of K-ras gene mutations in tumour and sputum DNA of patients with lung cancer Biomarkers 8 2003 156 161 (Pubitemid 36747951)
18. A. Destro, P. Bianchi, M. Alloisio, L. Laghi, S. Di Gioia, and A. Malesci K-ras and p16(INK4A)alterations in sputum of NSCLC patients and in heavy asymptomatic chronic smokers Lung Cancer 44 2004 23 32 (Pubitemid 38317259)
19. G. Ferretti, G. Curigliano, U. Pastorino, A. Cittadini, G. Flamini, and M.G. Calabro Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer Clin Cancer Res 6 2000 2393 2400 (Pubitemid 30399207)
20. R. Rosell, J. Gomez-Codina, C. Camps, J. Maestre, J. Padille, and A. Canto A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer N Engl J Med 330 1994 153 158 (Pubitemid 24026882)
21. S. Syngal, E. Stoffel, D. Chung, C. Willett, D. Schoetz, and P. Schroy Detection of stool DNA mutations before and after treatment of colorectal neoplasia Cancer 106 2006 277 283 (Pubitemid 43100434)
22. E. Majewska, M. Kasielski, R. Luczynski, G. Bartosz, P. Bialasiewicz, and D. Nowak Elevated exhalation of hydrogen peroxide and thiobarbituric acid reactive substances in patients with community acquired pneumonia Respir Med 98 2004 669 676 (Pubitemid 38949932)
23. K. Okudela, T. Woo, and H. Kitamura KRAS gene mutations in lung cancer: particulars established and issues unresolved Pathol Int 60 2010 651 660
24. J. Sambrook, and D. Russell Molecular cloning: a laboratory manual 2001 Cold Spring Harbor Laboratory Press New York
25. P. Nollau, C. Moser, G. Weinland, and C. Wagener Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR Int J Cancer 66 1996 332 336 (Pubitemid 26163607)
26. ImageMaster VDS Application Note #1. Imaging DNA agarose gels stained with ethidium bromide (80-6323-77).
27. M. Fleischhacker, and B. Schmidt Circulating nucleic acids (CNAs) and cancer-a survey Biochim Biophys Acta 1775 2007 181 232 (Pubitemid 44911084)
28. A.K. Pathak, M. Bhutani, S. Kumar, A. Mohan, and R. Guleria Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool Clin Chem 52 2006 1833 1842 (Pubitemid 44470688)
29. M. Stroun, P. Anker, P. Maurice, J. Lyautey, C. Lederrey, and M. Beljanski Neoplastic characteristics of the DNA found in the plasma of cancer patients Oncology 46 1989 318 322 (Pubitemid 19216753)
30. J. Jassem, E. Jassem, J. Jakobkiewicz-Banecka, W. Rzyman, A. Badzio, and R. Dziadziuszko P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma Cancer 100 2004 1951 1960 (Pubitemid 38529573)
31. S.M. Lang, D.F. Stratakis, A. Freudling, K. Ebelt, F. Oduncu, and H. Hautmann Detection of K-ras and p53 mutations in bronchoscopically obtained malignant and non-malignant tissue from patients with non-small cell lung cancer Eur J Med Res 5 2000 341 346
32. S.N. Tamkovich, O.E. Bryzgunova, E.Y. Rykova, V.I. Permyakova, V.V. Vlassov, and P.P. Laktionov Circulating nucleic acids in blood of healthy male and female donors Clin Chem 51 2005 1317 1319 (Pubitemid 43079438)
33. F. Oshita, I. Nomura, K. Yamada, Y. Kato, G. Tanaka, and K. Noda Detection of K-ras mutations of bronchoalveolar lavage fluid cells aids the diagnosis of lung cancer in small pulmonary lesions Clin Cancer Res 5 1999 617 620 (Pubitemid 29131972)
34. M.A. van der Drift, C.F. Prinsen, B.E. Hol, A.S. Bolijn, M.A. Jeunink, and P.N. Dekhuijzen Can free DNA be detected in sputum of lung cancer patients? Lung Cancer 61 2008 385 390
35. E.K. Risse, M.A. van't Hof, R.N. Laurini, and P.G. Vooijs Sputum cytology by the Saccomanno method in diagnosing lung malignancy Diagn Cytopathol 1 1985 286 291
36. A. Sing, N. Freudenberg, C. Kortsik, H. Wertzel, B. Klosa, and J. Hasse Comparison of the sensitivity of sputum and brush cytology in the diagnosis of lung carcinomas Acta Cytol 41 1997 399 408 (Pubitemid 27172506)
37. M. Kersting, C. Friedl, A. Kraus, M. Behn, W. Pankow, and M. Schuermann Differential frequencies of p16(INK4a) promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers J Clin Oncol 18 2000 3221 3229
38. E. Baryshnikova, A. Destro, M.V. Infante, S. Cavuto, U. Cariboni, and M. Alloisio Molecular alterations in spontaneous sputum of cancer-free heavy smokers: results from a large screening program Clin Cancer Res 14 2008 1913 1919 (Pubitemid 351469479)
39. G.J. Riely, M.G. Kris, D. Rosenbaum, J. Marks, A. Li, and D.A. Chitale Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma Clin Cancer Res 14 2008 5731 5734
40. J.L. Ramirez, C. Sarries, P.L. de Castro, B. Roig, C. Queralt, and D. Escuin Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients Cancer Lett 193 2003 207 216 (Pubitemid 36428904)
41. O. Gautschi, and A. Ziegler Comment on "Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-call lung cancer patients" (Cancer Letters 2003;193:207-216) Cancer Lett 204 1 2004
42. N. Konishi, Y. Hiasa, H. Matsuda, M. Tao, T. Tsuzuki, and I. Hayashi Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma Am J Pathol 147 1995 1112 1122
43. W. Giaretti, A. Rapallo, A. Sciutto, B. Macciocu, E. Geido, and M.A. Hermsen Intratumor heterogeneity of k-ras and p53 mutations among human colorectal adenomas containing early cancer Anal Cell Pathol 21 2000 49 57 (Pubitemid 32238922)
44. K. Taniguchi, J. Okami, K. Kodama, M. Higashiyama, and K. Kato Intratumor heterogeneity of epidermal growth factor receptor mutations in lung cancer and its correlation to the response to gefitinib Cancer Sci 99 2008 929 935 (Pubitemid 351997594)